Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP405723.RAzgbfyOVAuUc6GJ11DTuUpOJFN61wIegcN5QN6JMfeLk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP405723.RAzgbfyOVAuUc6GJ11DTuUpOJFN61wIegcN5QN6JMfeLk130_assertion type Assertion NP405723.RAzgbfyOVAuUc6GJ11DTuUpOJFN61wIegcN5QN6JMfeLk130_head.
- NP405723.RAzgbfyOVAuUc6GJ11DTuUpOJFN61wIegcN5QN6JMfeLk130_assertion description "[We analysed a microsatellite polymorphism (variant lengths of a dinucleotide (AT)n repeat) within exon 3 of the CTLA-4 gene in the following groups: 21 English patients with non-associated Addison's disease, 18 with autoimmune polyglandular syndrome type 2 (APS2) and 173 healthy control subjects; 26 Norwegian patients with non-associated Addison's disease, 9 with autoimmune polyglandular syndrome type 1 (APS1), 17 with APS2 and 100 controls; 3 Finnish patients with non-associated Addison's disease, 5 with APS2 and 71 controls; 10 Estonian patients with non-associated Addison's disease, 2 with APS2 and 45 controls.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP405723.RAzgbfyOVAuUc6GJ11DTuUpOJFN61wIegcN5QN6JMfeLk130_provenance.
- NP405723.RAzgbfyOVAuUc6GJ11DTuUpOJFN61wIegcN5QN6JMfeLk130_assertion evidence source_evidence_literature NP405723.RAzgbfyOVAuUc6GJ11DTuUpOJFN61wIegcN5QN6JMfeLk130_provenance.
- NP405723.RAzgbfyOVAuUc6GJ11DTuUpOJFN61wIegcN5QN6JMfeLk130_assertion SIO_000772 10197076 NP405723.RAzgbfyOVAuUc6GJ11DTuUpOJFN61wIegcN5QN6JMfeLk130_provenance.
- NP405723.RAzgbfyOVAuUc6GJ11DTuUpOJFN61wIegcN5QN6JMfeLk130_assertion wasDerivedFrom befree-20140225 NP405723.RAzgbfyOVAuUc6GJ11DTuUpOJFN61wIegcN5QN6JMfeLk130_provenance.
- NP405723.RAzgbfyOVAuUc6GJ11DTuUpOJFN61wIegcN5QN6JMfeLk130_assertion wasGeneratedBy ECO_0000203 NP405723.RAzgbfyOVAuUc6GJ11DTuUpOJFN61wIegcN5QN6JMfeLk130_provenance.